Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study

Hypertriglyceridemia, defined as a triglyceride measurement > 150 mg/dl, occurs in up to 34% of adults. Fenofibrate is a commonly used drug to treat hypertriglyceridemia, but response to fenofibrate varies considerably among individuals. We sought to determine if genetic variation in apolipoprote...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wojczynski, Mary K., Gao, Guimin, Borecki, Ingrid, Hopkins, Paul N., Parnell, Laurence, Lai, Chao-Qiang, Ordovas, Jose M., Chung, B. Hong, Arnett, Donna K.
Format: Artigo
Jezik:Inglês
Izdano: The American Society for Biochemistry and Molecular Biology 2010
Teme:
Patient-Oriented and Epidemiological Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952572/
https://ncbi.nlm.nih.gov/pubmed/20724655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P001834
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items